CD40LG and Lyme disease: Shortly after his clinic visit, the Borrelia burgdorferi serologic testing performed during his first visit to the ED was reported as reactive (tier 1 IgG/IgM ELISA: reactive; tier 2 anti-VlsE1+pepC10 IgG/IgM ELISA: reactive), confirming a diagnosis of Lyme disease.